Database Query Results : , , CDKN2A

CDKN2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4): Click to Expand ⟱
Source: CGL-Driver Genes
Type: TSG
CDKN2A is a vital tumor suppressor gene that plays a key role in regulating the cell cycle and maintaining genomic stability.
CDKN2A (Cyclin-Dependent Kinase Inhibitor 2A) is a crucial tumor suppressor gene that encodes two important proteins, p16INK4a and p14ARF, which play significant roles in regulating the cell cycle and cellular responses to stress.
Its inactivation is a common event in many cancers, contributing to tumorigenesis and disease progression.
The status of CDKN2A can serve as a prognostic marker in various cancers. Loss of CDKN2A expression is often associated with poor prognosis and more aggressive disease.
Scientific Papers found: Click to Expand⟱

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 0

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: CDKN2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:53  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page